Compare KD & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KD | PBH |
|---|---|---|
| Founded | 2020 | 1996 |
| Country | United States | United States |
| Employees | 80000 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2021 | 2004 |
| Metric | KD | PBH |
|---|---|---|
| Price | $13.01 | $48.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $25.92 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 3.5M | 406.7K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $15,092,000,000.00 | $975,777,000.00 |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $0.08 | $4.31 |
| P/E Ratio | ★ N/A | $81.62 |
| Revenue Growth | 0.23 | ★ 36.77 |
| 52 Week Low | $10.10 | $42.62 |
| 52 Week High | $32.97 | $71.07 |
| Indicator | KD | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 49.02 | 37.78 |
| Support Level | $12.10 | $47.61 |
| Resistance Level | $13.77 | $49.79 |
| Average True Range (ATR) | 0.52 | 1.36 |
| MACD | -0.03 | -0.37 |
| Stochastic Oscillator | 47.06 | 0.35 |
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.